Jaguar Health Inc (JAGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 9,385 | 5,775 | 4,416 | 4,361 | 142 |
| Cost of Goods | 3,280 | 3,816 | 2,766 | 880 | 52 |
| Gross Profit | 6,105 | 1,959 | 1,650 | 3,481 | 90 |
| Operating Expenses | 33,032 | 31,723 | 33,240 | 38,608 | 13,728 |
| Operating Income | -26,647 | -28,948 | -30,824 | -34,247 | -13,586 |
| Interest Expense | 2,792 | 5,731 | 2,629 | 1,210 | 986 |
| Other Income | -4,370 | -3,850 | 1,307 | 307 | -162 |
| Pre-tax Income | -33,809 | -38,529 | -32,146 | -35,150 | -14,734 |
| Income Tax | 0 | 10 | N/A | -13,181 | 0 |
| Net Income Continuous | -33,809 | -38,539 | -32,146 | -21,969 | -14,734 |
| Net Income | $-33,809 | $-38,539 | $-32,146 | $-21,969 | $-14,734 |
| EPS Basic Total Ops | -3.00 | -9.01 | -153.27 | -7.59 | -1.35 |
| EPS Basic Continuous Ops | -2.62 | -7.76 | -153.27 | -7.59 | -1.35 |
| EPS Diluted Total Ops | -3.00 | -9.01 | -153.27 | -7.59 | -1.35 |
| EPS Diluted Continuous Ops | -2.62 | -7.76 | -153.27 | -7.59 | -1.35 |
| EBITDA(a) | $-21,697 | $-21,863 | $-23,097 | $-16,235 | $-13,028 |